Monoclonal antibodies in the treatment of cancer (Q40201565)

18 September 2017

1 reference

title

Monoclonal antibodies in the treatment of cancer (English)

1 reference

18 September 2017

Dillman RO

1 reference

18 September 2017

language of work or name

1 reference

1 January 1984

1 reference

Critical Reviews in Oncology Hematology

18 September 2017

published in

1 reference

18 September 2017

1 reference

18 September 2017

1 reference

18 September 2017

page(s)

357-385

1 reference

Continuous cultures of fused cells secreting antibody of predefined specificity

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Monoclonal antibodies. A new technique for producing serologic reagents

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Cytolytic effects of alloantiserum in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Regression of a T-Cell Lymphoma after Administration of Antithymocyte Globulin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Therapy of mouse lymphoma with monoclonal antibodies to glycolipid: selection of low antigenic variants in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Monoclonal Antibodies Defining Distinctive Human T Cell Surface Antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

A monoclonal antibody to human acute lymphoblastic leukaemia antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Shedding from normal and cancer-cell surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Human hybridomas from malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Human monoclonal antibodies to lung-cancer antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Use of radiolabeled antibodies for localization of neoplasms. The state of the art.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Radionuclide Imaging of Metastases from Renal-Cell Carcinoma by131I-labeled Antitumor Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

The Role of Radioimmunodetection in the Management of Testicular Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Clinical radioimmunodetection of cancer with radioactive antibodies to human chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Radioimmunodetection of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Tumor imaging with radioactive metal chelates conjugated to monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Tumour localisation with monoclonal antibody radioactivity labelled with metal chelate rather than iodine

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Tumor Location Detected with Radioactively Labeled Monoclonal Antibody and External Scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Localization of mammary tumors in vivo with 131I-labeled Fab fragments of antibodies against mouse mammary epithelial (MME) antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

In vivo tumor localization using tumor-specific monkey xenoantibody, alloantibody, and murine monoclonal xenoantibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Diagnostic imaging of malignant melanoma with radiolabeled antitumor antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Cellular distribution of monoclonal antibody in human tumours after i.v. administration

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Localization of human tumour xenografts after i.v. administration of radiolabeled monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

THE CATABOLISM OF HOMOLOGOUS AND HETEROLOGOUS 7S GAMMA GLOBULIN FRAGMENTS

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Antibody Mediated Delivery of Toxic Molecules to Antigen Bearing Target Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Targeting of drugs: implications in medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Anti-transferrin receptor monoclonal antibody and toxin–antibody conjugates affect growth of human tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

1 reference

7 January 2021

Antibody as carrier of chlorambucil

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Suppression of an AKR Lymphoma by Antibody and Chlorambucil2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Tumor inhibition by chlorambucil covalently linked to antitumor globulin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Immunochemotherapy of malignant melanoma with chlorambucil-bound antimelanoma globulins: preliminary results in patients with disseminated disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Kettering Award Lecture. The role of marrow transplantation in the eradication of malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

Selective killing of leukaemia cells by antibody-toxin conjugates: implications for autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

High-dose combined-modality therapy and autologous bone marrow transplantation in resistant cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2884%2980008-6

7 January 2021

10.1016/S1040-8428(84)80008-6

Identifiers

DOI

1 reference

18 September 2017

1 reference